Arcellx (ACLX) Operating Leases (2022 - 2025)

Arcellx's quarterly Operating Leases came in at $44.3 million in Q4 2025, down 4.73% year-on-year from $46.5 million in Q4 2024, and little changed quarter-over-quarter from $44.3 million in Q3 2025.

Arcellx has reported Operating Leases for 4 years, with the latest figure at $44.3 million in Q4 2025.

  • For the quarter ending Q4 2025, Operating Leases fell 4.73% year-over-year to $44.3 million; the trailing twelve-month figure through Dec 2025 stood at $44.3 million (down 4.73% YoY), and the FY2025 full-year result was $44.3 million, down 4.73% from the prior year.
  • Operating Leases for Q4 2025 stood at $44.3 million, roughly flat from $44.3 million in the prior quarter.
  • The five-year high for Operating Leases was $50.8 million in Q4 2023, with the low at $4.5 million in Q1 2022.
  • Average Operating Leases over 4 years is $39.5 million, with a median of $44.7 million recorded in 2025.
  • Year-over-year, Operating Leases jumped 614.63% in 2023 and dropped 8.46% in 2024.
  • Tracing ACLX's Operating Leases over 4 years: stood at $31.3 million in 2022, then jumped by 62.44% to $50.8 million in 2023, then decreased by 8.46% to $46.5 million in 2024, then declined by 4.73% to $44.3 million in 2025.
  • The last three Operating Leases figures came in at $44.3 million (Q4 2025), $44.3 million (Q3 2025), and $45.1 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Arcellx 6.48 Bn 6.48 Bn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 44.34 Mn
Sep 30, 2025 44.32 Mn
Jun 30, 2025 45.10 Mn
Mar 31, 2025 45.83 Mn
Dec 31, 2024 46.54 Mn
Sep 30, 2024 47.21 Mn
Jun 30, 2024 47.87 Mn
Mar 31, 2024 47.69 Mn
Dec 31, 2023 50.84 Mn
Sep 30, 2023 48.10 Mn
Jun 30, 2023 40.64 Mn
Mar 31, 2023 31.99 Mn
Dec 31, 2022 31.30 Mn
Sep 30, 2022 29.21 Mn
Jun 30, 2022 27.20 Mn
Mar 31, 2022 4.48 Mn